Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Glioblastoma 3Skin Diseases 2Precancerous Conditions 2Keratosis, Actinic 2Squamous Cell Carcinoma of Head and Neck 1Mouth Neoplasms 1Meningioma 1Lichen Planus, Oral 1Leukoplakia, Oral 1Kidney Neoplasms 1Glioma 1Colorectal Neoplasms 1Carcinoma, Basal Cell 1Carcinoma in Situ 1

Interventions

dodecyl maltoside 2Magnetic Resonance Imaging 2Electrocardiography 2Diphenhydramine 2Acetaminophen 2fludarabine phosphate 1fludarabine 1durvalumab 1aldesleukin 1Tomography, X-Ray Computed 1Respiratory Function Tests 1Prochlorperazine 1Positron-Emission Tomography 1Ondansetron 1O(6)-codeine methyl ether 1Meperidine 1Mastectomy, Subcutaneous 1Loperamide 1Interleukin-2 1Innovar 1Indomethacin 1Hydroxyzine 1Histamine Antagonists 1Granisetron 1Droperidol 1Doxylamine 1Docetaxel 1Diphenoxylate 1Cystoscopy 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma in Situ × Aminolevulinic Acid × 90 days × Clear all
NCT06876038 2026-03-19

Low-cost Screening and Image-guided Photodynamic Therapy (PDT) of Premalignant and Malignant Oral Lesions

University of Massachusetts, Boston

Phase 2 Not yet recruiting
65 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma in Situ, Leukoplakia, Oral, Mouth Neoplasms, Lichen Planus, Oral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡